Portfolio comparison
Washington University in St. Louis vs Curevac SE
Side-by-side portfolio analysis — patents indexed, year ranges, and activity timeline.
Company A
Washington University in St. Louis
Patents indexed
1
Year range
2026
Most recent
2026
biotechpharmaceuticalgene_editingoncology
Top Patents1 enriched
US 12564648· 2026
Gene Editing T-Cells to Fight CD7 Blood Cancers
Activity by Decade
2020s1
Company B
Curevac SE
Patents indexed
4
Year range
2023 – 2024
Most recent
2024
biotechpharmaceuticaloncologygene_editingsemiconductors
Top Patents4 enriched
US 11692002· 2023
Making RNA for Vaccines More Consistent
US 12048738· 2024
Using mRNA to Teach the Body to Fight Prostate Cancer
US 12083190· 2024
How an mRNA Vaccine Teaches Your Body to Fight Rabies
Activity by Decade
2020s3
How to use
Bookmark a comparison URL to save it. Format: /compare/companies?a=[slug]&b=[slug]. Also see patent-level comparison.